New NICE bisphosphonate guidance
The following information is taken from the NOS. Leading osteoporosis experts have warned GPs and healthcare professionals to exercise caution over recently issued guidance about the use of bisphosphonates. The new guidance, published by NICE during the summer, incorporates both fracture risk assessment tools and the availability of low-cost generic forms of bisphosphonates and concludes these drugs are cost-effective at...
Read More